Snowball logo
logo
  • Stocks
  • Japan
  • Healthcare
4536

Santen Pharmaceutical Co Ltd

4536 • TSE
¥1,673.50-¥20.00  (1.18%)
Start your journey to financial independence ✨
Snowball will help you to track your portfolio, plan deposits to your brokerage account and support your passive income strategy with tools and community of investors
Start

Frequently asked questions

What sector does Santen Pharmaceutical Co Ltd (4536) operate in?

Santen Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.

What is Santen Pharmaceutical Co Ltd (4536) current stock price?

As of the latest data, Santen Pharmaceutical Co Ltd stock price is ¥1,674, with a previous close of ¥1,694. Santen Pharmaceutical Co Ltd lost -¥20 in the last trading session, representing a -1.18% loss.

What is Santen Pharmaceutical Co Ltd (4536) current market capitalization?

Santen Pharmaceutical Co Ltd market cap is approximately 569.69 billion.

What is Santen Pharmaceutical Co Ltd (4536) Earnings Per Share (EPS)?

The trailing EPS is ¥104.

What is Santen Pharmaceutical Co Ltd (4536) Price-to-Earnings (P/E) ratio?

Santen Pharmaceutical Co Ltd current P/E ratio is 16.13.

What is Santen Pharmaceutical Co Ltd (4536) EBITDA?

Santen Pharmaceutical Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 18.66 billion.

Does Santen Pharmaceutical Co Ltd (4536) pay dividends?

Yes. Santen Pharmaceutical Co Ltd pays semiannual dividends with an annualized yield of 2.27% and an estimated annual payout of ¥38 per share.

When is the next ex-dividend date for Santen Pharmaceutical Co Ltd (4536)?

The next ex-dividend date is scheduled for September 28, 2025.

How did Santen Pharmaceutical Co Ltd (4536) perform in its most recent earnings report?

In the last report (March 31, 2025), Santen Pharmaceutical Co Ltd posted an EPS surprise of 61.09% and a revenue surprise of -74.18%.

When is Santen Pharmaceutical Co Ltd (4536) next earnings report?

Santen Pharmaceutical Co Ltd is expected to release its next earnings report on June 30, 2025.

What is Santen Pharmaceutical Co Ltd (4536) beta (volatility) score?

Santen Pharmaceutical Co Ltd has a beta of 0.215, indicating lower volatility than the overall market.
2025 © Snowball Analytics
𝕏
Snowball Analytics SAS914 331 640 R.C.S. LYON
Greffe du tribunal de Commerce de LYONAddress: LE FORUM 27 RUE MAURICE FLANDIN
LYON CEDEX 3, 69444, FranceEmail: help@snowball-analytics.com
Get the Snowball Analytics app
Download Snowball Analytics on App Store
4.8 • 2500 ratings
Download Snowball Analytics mobile android app
4.7 • 1300 ratings
Powered by EODHD, SnapTrade
ProductPortfolio trackerStock trackerDividend trackerDividend calendarSharesight vs. Dividend.Watch vs. Snowball AnalyticsPricing
ResourcesTerms and conditionsPrivacy policySecurityYodleeAbout usContacts
Support Support Knowledge Base
Snowball Analytics would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The site and content, are provided “as is” and without warranties of any kind. You bear all risks associated with the use of the site and content, including without limitation, any reliance on the accuracy, completeness or usefulness of any content available on the site. The Website should not be relied upon as a substitute for extensive independent market research before making your actual trading decisions. Past performance is not an indicator of future performance. Snowball Analytics is not a registered investment advisor or broker/dealer. Any opinions, charts, messages, news, research, analyses, prices, or other information contained on this Website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice.
Interactive Brokers is not affiliated with Snowball Analytics and does not endorse or recommend any information or advice provided by Snowball Analytics.